Acclinate: Funding, Investors & Team (Sep 2026)
Acclinate is a healthcare technology company dedicated to transforming the process of clinical trials. The company focuses on involving diverse communities and increasing representation of people of color in these trials, which helps to address crucial health equity issues. Their strategy involves ongoing community involvement paired with the use of cutting-edge AI/ML technology.
Acclinate has raised $11.9M across 2 funding rounds on record, the most recent a Series A of $7.0M announced in May 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Acclinate Company Profile and Key Stats
Latest funding round on record: May 2024.
Acclinate Funding Rounds
Acclinate raised $4.9M in an undisclosed round announced in Oct 2022.
1.6 years later, a Series A of $7.0M was announced in May 2024.
Acclinate Founders and Leadership Team
Contact details for the Acclinate team: 1 of 1 has an email address on file.
Start 14-day free trial →Acclinate Funding Compared to Other Biotechnology Startups
Acclinate's latest round of $7.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Acclinate in Biotechnology and Birmingham
Companies Similar to Acclinate
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Acclinate Funding FAQs
What does Acclinate do?
Acclinate is a healthcare technology company dedicated to transforming the process of clinical trials. The company focuses on involving diverse communities and increasing representation of people of color in these trials, which helps to address crucial health equity issues. Their strategy involves ongoing community involvement paired with the use of cutting-edge AI/ML technology.
How much funding has Acclinate raised?
Acclinate has raised $11.9M across 2 rounds on record. The most recent is a Series A of $7.0M announced in May 2024.
When did Acclinate last raise funding?
Acclinate's most recent funding round on record is a Series A of $7.0M, announced in May 2024.
Who founded Acclinate?
FundedIQ lists Tiffany Whitlow (Founder) at Acclinate.
Where is Acclinate headquartered?
Acclinate is based in Birmingham, Alabama, United States.
How many employees does Acclinate have?
Acclinate is in the 11-50 employee band.
How does Acclinate's funding compare to other Biotechnology startups?
Acclinate's latest round of $7.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Acclinate Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Acclinate is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.